anlon-healthcare-ltd Share Price Today - anlon-healthcare-ltd Stock Price Live NSE/BSE

NSE: undefined BSE: undefined

₹-

(-%)

Sun, 26 Apr 2026, 00:20 pm

MTF 5xInvest in with 5x Leverage Buy with MTF

Market Cap-

PE Ratio-

Dividend-

24.5K

Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
-
Net Profit
-
P/B
-
Sector P/E
-
P/E
-
EV/EBITDA
-
Debt/Equity (Industry)
-
Interest Cover (Industry)
-
ROCE (Industry)
-
RONW (Industry)
-
ROE
-
ROCE
-
Debt/Equity
-
EPS (TTM)
-
Dividend Yield
-
Book Value
-
Interest Cover
-

Analysis

No Result Found

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025
Promoters	52.68	52.68	52.68
FII	0.32	0.23	0.00
DII	4.60	4.49	2.83
Public	42.40	42.60	44.49
Government	0	0	0

Technical Analysis

RSI

79.41

MACD

0.84

50 DMA

12.23

200 DMA

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	17.46	14.53	12.83	11.60	9.91	8.67	5.74
Fibonacci	14.53	13.41	12.72	11.60	10.48	9.79	8.67
Camarilla	11.94	11.67	11.41	11.60	10.87	10.60	10.33

Pivots Level: Classic

+5.86

17.46

+2.93

14.53

+1.23

12.83

11.60

Pivot Point

LTP: 15.87

-1.70

9.91

-2.93

8.67

-5.86

5.74

Moving Average

SMAEMA

Period

Value

10-EMA
14.16
20-EMA
13.38
30-EMA
13.01
50-EMA
12.77
100-EMA
12.77
200-EMA
-

Announcement Date	Purpose	Action	Ex Date
10 Apr 2026	bonus	1:1 Bonus Issue of Equity Shares	24 Apr 2026
06 Mar 2026	split	1:5 Splits of Equity Shares	24 Apr 2026
09 Feb 2026	board-meetings	Quarterly Results

Anlon Healthcare Ltd

Linde India Ltd

SRF Ltd

Pidilite Industries Ltd

Gujarat Fluorochemicals Ltd

Godrej Industries Ltd

About

Anlon Healthcare are a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates (“Pharma Intermediate”) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients (“APIs”) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (“FDF”) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Our products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. Our active pharmaceutical ingredient products are manufactured in accordance with Indian and international pharmacopeia standards such as IP, BP, EP, JP, USP. We face competitions from various listed peers including Kronox Labscience Limited, AMI Organics Limited, Supriya Lifescience Limited, etc.

Industry

Chemicals

Founded

2013

Headquarters

CEO

Punitkumar R Rasadia

Employees

Contact

Website

http://www.anlon.in

cs@anloncro.com

Phone

+91 281 2562538/39

Location

101/102 Silvercoin Complex Opp, Crystal Mall Kalawad Road, Rajkot, Gujarat, 360005

Year	History
2017	The company received ISO 9001:2015 certification. The company started trial production of pharma intermediates and APIs.
2018	The company commenced commercial production of Pharma Intermediate and API. The company made its first export of its product to South Korea.
2019	The company received Good Manufacturing Practice certification for its Manufacturing Facility. The company received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan.
2021	The company received Good Manufacturing Practice – World Health Organization Certification for its Manufacturing Facility.
2024	The company received approval for Drug Master File from Brazilian Health Regulatory Agency for its API product loxoprofen sodium dihydrate. The company was converted to a public limited company and its name was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.

Client Name	Order Side	QTY	Avg Price	Date
NEOMILE GROWTH FUND-SERIES I	Sell	2099779	16.31	24 Apr 2026
NEOMILE GROWTH FUND-SERIES I	Sell	2099779	16.31	24 Apr 2026
NEOMILE GROWTH FUND-SERIES I	Buy	400000	125	21 Jan 2026
NEOMILE GROWTH FUND-SERIES I	Buy	400000	125	21 Jan 2026
NEOMILE CORPORATE ADVISORY LIMITED	Sell	407499	125	21 Jan 2026
NEOMILE CORPORATE ADVISORY LIMITED	Sell	407499	125	21 Jan 2026
NEOMILE CORPORATE ADVISORY LIMITED	Sell	457973	141.98	10 Nov 2025
NEOMILE CORPORATE ADVISORY LIMITED	Sell	457973	141.98	10 Nov 2025
NEOMILE CORPORATE ADVISORY LIMITED	Sell	760927	130.46	04 Nov 2025
NEOMILE CORPORATE ADVISORY LIMITED	Sell	760927	130.46	04 Nov 2025

News

Anlon Healthcare Gets New ISIN for Share Split

Anlon Healthcare Limited receives new ISIN INE0Y8W01025 from depositories for equity share subdivision from Rs. 10 to Rs. 2, effective April 24, 2026.

22 Apr 2026

companies

Anlon Healthcare Acquires 63.98% Stake in Remember India

Anlon Healthcare approves acquisition of 63.98% stake in Remember India Health Links for ₹5.38 crore to expand pharmaceutical capabilities and establish it as a subsidiary company.

16 Apr 2026

companies

Anlon Healthcare Acquires 63.98% Stake in Remember India

Anlon Healthcare approves acquisition of 63.98% stake in Remember India Health Links for ₹5.38 crore to expand pharmaceutical capabilities and establish it as a subsidiary company.

16 Apr 2026

companies

Anlon Healthcare Acquires 63.98% Stake in Remember India

Anlon Healthcare approves acquisition of 63.98% stake in Remember India Health Links for ₹5.38 crore to expand pharmaceutical capabilities and establish it as a subsidiary company.

16 Apr 2026

companies

Anlon Healthcare Gets Credit Rating Withdrawal

Anlon Healthcare Limited announces Brickwork Ratings has withdrawn credit ratings for bank loan facilities worth Rs.24.50 crores and term loans of Rs.10.36 crores following facility closure.

15 Apr 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800

Share Price Live Chart

Summary

Analysis

Financials

Ratios

Shareholding

Technical Analysis

Corporate Actions

Peer Comparison

About

Contact

Company History

Deals

News